SteadyMed Therapeutics Finds $3M In Working Capital

San Ramon-based SteadyMed Therapeutics, a developer of biopharmaceuticals to treat Pulmonary Arterial Hypertension (PAH), has raised $3M in a term loan from Square 1 Bank. Square 1 Bank said the loan will go towards working capital, to help the firm continue development of its technology. Terms of the loan were not announced by Square 1.